Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs GnRH Antagonist in ICSI
NCT06868576Phase 3Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2023
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of dydrogesterone in infertility (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Clinical Pregnancy. Started Jan 2023; status: completed.
02
Drugs
dydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06868576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06868576.